CRUK Therapeutic Discovery Laboratories

lbic_CRUK.png
 

Cancer Research UK's Therapeutic Discovery Laboratories (CRUK-TDL), formerly CRT Discovery Laboratories, is the in-house Cancer Research UK drug discovery unit with a principal focus on establishing and prosecuting biologically-themed multi-project alliances with industry. Our expertise spans cancer target validation and disease positioning, immunology, assay development and HTS, protein crystallography, medicinal chemistry, PK-PD and cancer models. Through our alliance approach, we align these key skills with internationally competitive academic research and the development capabilities of industry partners to maximise cancer patient benefit. 

More information on CRUK-TDL can be found at our website